BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32373950)

  • 1. Long noncoding RNA SNHG16 acts as an oncogene in Wilms' tumor through sponging miR-200a-3p.
    Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4145-4151. PubMed ID: 32373950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer.
    Guo JQ; Yang ZJ; Wang S; Wu ZZ; Yin LL; Wang DC
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1718-1724. PubMed ID: 32141539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA SNHG16 acts as an oncogene in Wilms' tumor through sponging miR-200a-3p.
    Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7562. PubMed ID: 32744667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
    Bao J; Zhang S; Meng Q; Qin T
    Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p.
    Li Y; Lu Y; Chen Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
    Chen W; Jiang T; Mao H; Gao R; Zhang H; He Y; Liu C; Chen Q
    Hum Cell; 2020 Jul; 33(3):737-749. PubMed ID: 32207096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
    Shen J; Shu Q
    Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
    Chen ZH; Cui MY; Zhang HM
    Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
    Zhu KR; Sun QF; Zhang YQ
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p.
    Zhang C; Wang GX; Fu B; Zhou XC; Li Y; Li YY
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8303-8309. PubMed ID: 31646560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non Coding RNA SNHG16 Facilitates Proliferation, Migration, Invasion and Autophagy of Neuroblastoma Cells via Sponging miR-542-3p and Upregulating ATG5 Expression.
    Wen Y; Gong X; Dong Y; Tang C
    Onco Targets Ther; 2020; 13():263-275. PubMed ID: 32021273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA SNHG16 Activates USP22 Expression to Promote Colorectal Cancer Progression by Sponging miR-132-3p.
    He X; Ma J; Zhang M; Cui J; Yang H
    Onco Targets Ther; 2020; 13():4283-4294. PubMed ID: 32547062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA SNHG16 promotes lipopolysaccharides-induced acute pneumonia in A549 cells via targeting miR-370-3p/IGF2 axis.
    Zhang J; Mao F; Zhao G; Wang H; Yan X; Zhang Q
    Int Immunopharmacol; 2020 Jan; 78():106065. PubMed ID: 31841752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells.
    Xu Z; Sun Y; Wang D; Sun H; Liu X
    Cancer Cell Int; 2020; 20():236. PubMed ID: 32536824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
    Wei S; Wang K; Huang X; Zhao Z; Zhao Z
    Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MIAT acts as an oncogene in Wilms' tumor through regulation of DGCR8.
    Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10257-10263. PubMed ID: 31841180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting as ceRNA to Sponge miR-520a-3p and Upregulate MAPK1 Expression.
    Wu Q; Zhao Y; Shi R; Wang T
    Cancer Manag Res; 2021; 13():4103-4114. PubMed ID: 34045897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-483-3p Promotes Proliferation, Migration, and Invasion and Induces Chemoresistance of Wilms' Tumor Cells.
    Che G; Gao H; Tian J; Hu Q; Xie H; Zhang Y
    Pediatr Dev Pathol; 2020; 23(2):144-151. PubMed ID: 31498707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma.
    Xu H; Miao X; Li X; Chen H; Zhang B; Zhou W
    Cancer Cell Int; 2021 Jan; 21(1):51. PubMed ID: 33435953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.